Thompson Travis Alvin 4

What Happened

• Travis (Travis Alvin Thompson), Chief Financial Officer of Bicycle Therapeutics plc (BCYC), sold a total of 923 shares in two open-market transactions to satisfy tax withholding on RSU vesting. He sold 819 shares on 2026-07-02 for a weighted average price of $4.27 (proceeds ~$3,497) and 104 shares on 2026-07-06 for a weighted average price of $4.31 (proceeds ~$448). These were sales (not purchases) and were mandated as "sell-to-cover" for statutory tax withholding rather than discretionary sell orders.

Key Details

• Transaction dates and prices:
  • 2026-07-02: 819 shares sold, weighted avg $4.27 (prices ranged $4.26–$4.29 per filing) — proceeds ~$3,497. (Footnote F2)
  • 2026-07-06: 104 shares sold, weighted avg $4.31 (prices ranged $4.30–$4.31 per filing) — proceeds ~$448. (Footnote F3)
• Total shares sold: 923; total reported proceeds: approx. $3,945.
• Reason/footnote: Footnote F1 states these sales were required to cover statutory tax withholding tied to RSU vesting (a mandated "sell-to-cover"), not discretionary sales.
• Shares owned after transaction: not specified in the provided filing.
• Filing timing: Report lists transaction date 2026-07-02 with a filing date of 2026-07-07 (filed 5 days after the first transaction); this appears later than the standard 2-business-day Form 4 reporting window.

Context

• "Sell-to-cover" transactions are common when restricted stock units vest and typically do not signal a change in an insider's view of the company; they are routine tax-related dispositions rather than voluntary portfolio moves.
• For retail investors, purchases by insiders tend to carry more forward-looking informational value than routine tax-related sales.